S&P 500   4,225.64 (+0.48%)
DOW   33,008.94 (-0.26%)
QQQ   353.22 (+1.38%)
AAPL   177.77 (+1.33%)
MSFT   336.63 (+1.12%)
META   267.18 (+1.96%)
GOOGL   126.24 (+1.31%)
AMZN   121.99 (+1.57%)
TSLA   200.49 (+3.79%)
NVDA   406.34 (+4.33%)
NIO   7.75 (+0.65%)
BABA   80.50 (-0.58%)
AMD   130.65 (+2.85%)
T   15.49 (-0.06%)
F   12.58 (+4.05%)
MU   74.60 (+0.91%)
CGC   0.89 (+0.88%)
GE   103.00 (+0.25%)
DIS   89.17 (+1.00%)
AMC   4.75 (+2.37%)
PFE   37.40 (-0.53%)
PYPL   61.01 (+1.31%)
NFLX   399.15 (+5.35%)
S&P 500   4,225.64 (+0.48%)
DOW   33,008.94 (-0.26%)
QQQ   353.22 (+1.38%)
AAPL   177.77 (+1.33%)
MSFT   336.63 (+1.12%)
META   267.18 (+1.96%)
GOOGL   126.24 (+1.31%)
AMZN   121.99 (+1.57%)
TSLA   200.49 (+3.79%)
NVDA   406.34 (+4.33%)
NIO   7.75 (+0.65%)
BABA   80.50 (-0.58%)
AMD   130.65 (+2.85%)
T   15.49 (-0.06%)
F   12.58 (+4.05%)
MU   74.60 (+0.91%)
CGC   0.89 (+0.88%)
GE   103.00 (+0.25%)
DIS   89.17 (+1.00%)
AMC   4.75 (+2.37%)
PFE   37.40 (-0.53%)
PYPL   61.01 (+1.31%)
NFLX   399.15 (+5.35%)
S&P 500   4,225.64 (+0.48%)
DOW   33,008.94 (-0.26%)
QQQ   353.22 (+1.38%)
AAPL   177.77 (+1.33%)
MSFT   336.63 (+1.12%)
META   267.18 (+1.96%)
GOOGL   126.24 (+1.31%)
AMZN   121.99 (+1.57%)
TSLA   200.49 (+3.79%)
NVDA   406.34 (+4.33%)
NIO   7.75 (+0.65%)
BABA   80.50 (-0.58%)
AMD   130.65 (+2.85%)
T   15.49 (-0.06%)
F   12.58 (+4.05%)
MU   74.60 (+0.91%)
CGC   0.89 (+0.88%)
GE   103.00 (+0.25%)
DIS   89.17 (+1.00%)
AMC   4.75 (+2.37%)
PFE   37.40 (-0.53%)
PYPL   61.01 (+1.31%)
NFLX   399.15 (+5.35%)
S&P 500   4,225.64 (+0.48%)
DOW   33,008.94 (-0.26%)
QQQ   353.22 (+1.38%)
AAPL   177.77 (+1.33%)
MSFT   336.63 (+1.12%)
META   267.18 (+1.96%)
GOOGL   126.24 (+1.31%)
AMZN   121.99 (+1.57%)
TSLA   200.49 (+3.79%)
NVDA   406.34 (+4.33%)
NIO   7.75 (+0.65%)
BABA   80.50 (-0.58%)
AMD   130.65 (+2.85%)
T   15.49 (-0.06%)
F   12.58 (+4.05%)
MU   74.60 (+0.91%)
CGC   0.89 (+0.88%)
GE   103.00 (+0.25%)
DIS   89.17 (+1.00%)
AMC   4.75 (+2.37%)
PFE   37.40 (-0.53%)
PYPL   61.01 (+1.31%)
NFLX   399.15 (+5.35%)
NASDAQ:BNTX

BioNTech (BNTX) Earnings Date, Estimates & Call Transcripts

$105.35
+0.08 (+0.08%)
(As of 09:09 AM ET)
Compare
Today's Range
$105.35
▼
$105.35
50-Day Range
$102.58
▼
$133.68
52-Week Range
$100.08
▼
$188.99
Volume
8,647 shs
Average Volume
700,054 shs
Market Capitalization
$25.62 billion
P/E Ratio
4.05
Dividend Yield
N/A
Price Target
$172.20
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 8)
$2.05 Beat By $1.87
Consensus EPS
(May. 8)
$0.18
Last Year's Q2 EPS
(5/9/2022)
$15.98
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BNTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BNTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioNTech Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.88)$2.00$0.92
Q2 20233($3.12)$1.86($0.04)
Q3 20233$0.59$1.21$0.99
Q4 20233$0.20$6.39$2.51
FY 202312($3.21)$11.46$4.37
Q1 20241($1.02)($1.02)($1.02)
Q2 20241($1.05)($1.05)($1.05)
Q3 20241$2.61$2.61$2.61
Q4 20241$2.76$2.76$2.76
FY 20244$3.30$3.30$3.30

BNTX Earnings Date and Information

BioNTech last issued its quarterly earnings data on May 8th, 2023. The reported $2.05 earnings per share for the quarter, topping the consensus estimate of $0.18 by $1.87. The business earned $1.28 billion during the quarter, compared to analysts' expectations of $1.09 billion. Its revenue for the quarter was down 80.0% compared to the same quarter last year. BioNTech has generated $26.01 earnings per share over the last year ($26.01 diluted earnings per share) and currently has a price-to-earnings ratio of 4.1. Earnings for BioNTech are expected to decrease by -51.29% in the coming year, from $5.42 to $2.64 per share. BioNTech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off prior year's report dates.

BioNTech Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2023
(Estimated)		        
5/8/20233/31/2023$0.18$2.05+$1.87$2.20$1.09 billion$1.28 billion    
3/27/202312/31/2022$8.04$9.26+$1.22$9.46$3.87 billion$4.28 billion    
11/7/2022Q3 2022$3.66$7.04+$3.38$7.04$1.90 billion$3.46 billion    
8/8/2022Q2 2022$7.69$7.31($0.38)$7.31$4.11 billion$3.20 billion    
5/9/2022Q1 2022$9.14$15.98+$6.84$15.98$4.50 billion$6.37 billion    
3/30/2022Q4 2021$8.02$13.93+$5.91$13.93$3.83 billion$5.53 billion    
11/8/20219/30/2021$10.54$12.35+$1.81$14.56$5.02 billion$6.09 billion    
8/8/20216/30/2021$8.35$10.77+$2.42$12.98$3.27 billion$5.31 billion    
5/9/20213/31/2021$3.09$4.39+$1.30$5.29$1.40 billion$2.05 billion  
3/29/202112/31/2020($0.56)$1.57+$2.13$1.87$98.29 million$412.00 million  
11/15/20209/30/2020($0.37)($0.88)($0.51)($1.03)$50.53 million$67.50 million  
8/11/20206/30/2020($0.06)($0.38)($0.32)($0.42)$84.52 million$41.80 million  
5/12/2020Q1 2020($0.30)($0.26)+$0.04($0.26)$27.90 million$30.51 million
3/31/2020Q4 2019($0.19)($0.29)($0.10)($0.29)$32.86 million$31.00 million
11/14/2019Q3 2019($0.21)($0.16)+$0.05($0.16)$28.83 million$31.87 million












BioNTech Earnings - Frequently Asked Questions

When is BioNTech's earnings date?

BioNTech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off last year's report dates. Learn more on BNTX's earnings history.

Did BioNTech beat their earnings estimates last quarter?

In the previous quarter, BioNTech (NASDAQ:BNTX) reported $2.05 earnings per share (EPS) to beat the analysts' consensus estimate of $0.18 by $1.87. Learn more on analysts' earnings estimate vs. BNTX's actual earnings.

How can I listen to BioNTech's earnings conference call?

The conference call for BioNTech's latest earnings report can be listened to online. Listen to Conference Call

How can I read BioNTech's conference call transcript?

The conference call transcript for BioNTech's latest earnings report can be read online. Read Transcript

How much revenue does BioNTech generate each year?

BioNTech (NASDAQ:BNTX) has a recorded annual revenue of $18.24 billion.

How much profit does BioNTech generate each year?

BioNTech (NASDAQ:BNTX) has a recorded net income of $9.94 billion. BNTX has generated $26.01 earnings per share over the last four quarters.

What is BioNTech's price-to-earnings ratio?

BioNTech (NASDAQ:BNTX) has a trailing price-to-earnings ratio of 4.05 and a forward price-to-earnings ratio of 19.44.

What is BioNTech's EPS forecast for next year?

BioNTech's earnings are expected to decrease from $5.42 per share to $2.64 per share in the next year, which is a -51.29% change.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:BNTX) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -